JR Finkelmeier is Chief Executive Officer of PaceMate, the leading cardiac remote monitoring and intelligent data management platform. As CEO, JR is driving PaceMate’s operational scale and commercial expansion as the company meets growing demand from top health systems seeking to modernize cardiac care.

He joined PaceMate in May 2024 as Chief Commercial Officer, bringing more than two decades of experience leading growth in healthcare and medical technology. Prior to PaceMate, JR served as Business Leader of ECG Solutions at Philips—a multi-hundred-million-dollar global business unit formerly known as BioTelemetry, which Philips acquired for $2.8 billion in 2021. There, he led a team of over 1,000 supporting remote cardiac monitoring for more than two million patients annually. His leadership included spearheading the acquisition and integration of medical-grade AI innovator Cardiologs and driving operational and commercial transformation across multiple markets.

A strategic operator with deep product, commercial, and clinical insight, JR has built a career focused on delivering scalable solutions that improve outcomes and simplify complex care delivery. At PaceMate, he continues this mission by expanding access to real-time, cloud-based cardiac monitoring that enables clinicians to deliver faster, more informed care.

JR holds a bachelor's degree from the University of Notre Dame and lives in Pennsylvania with his wife and two children.

As PaceMate’s President and Chief Financial Officer, Chandler Yoquelet is responsible for all of the company’s product, professional services, financial, risk, and technological aspects, including R&D, clinical operations, financial reporting, accounting, legal, and IT.

His expertise and passion lie in building a highly engaged cohesive team to support PaceMate’s growth.

Prior to PaceMate, Chandler served in various senior leadership roles within med tech and professional services industries, overseeing finance and operational functions with a focus on organizational transformation and scaling. He was also an audit manager with Grant Thornton, LLP, where he started his professional career.

Chandler received his bachelor’s degree in accounting from the University of South Florida and is an active-license Florida CPA.

Gabe Rosu is the CTO and co-founder of PaceMate, where he leads the technology vision and innovation.

With a strong background in enterprise architecture, cybersecurity, cloud computing and software development, Gabe has been instrumental in building scalable systems and driving the company's growth from the ground up. His passion for cutting-edge solutions and commitment to excellence ensures that PaceMate stays at the forefront of the industry.

As Senior Vice President of Sales and Marketing at PaceMate, Ryan Barone leads the company’s Sales, Marketing, and Business Development functions. He brings over two decades of experience in the biotechnology, medical device, and healthcare technology sectors, with a proven track record in strategic execution, commercial leadership, and the successful adoption of innovative technologies.
 
Prior to joining PaceMate, Ryan held leadership positions in sales and business development at organizations including Quintiles Medical Research and Intuitive Surgical. In addition to his operational roles, he is an active venture capital investor, advisor, and board member to several high-growth technology and AI companies.
 
Ryan holds a Bachelor’s degree in Business Administration and Management from the University of Tampa and earned his MBA in Finance and Entrepreneurship from Syracuse University’s Whitman School of Management.

Recognized as one of the Top 25 Women Leaders in Medical Devices for 2021 and 2022, Noemi Ray leads PaceMate as Senior Vice President of Clinical Operations.

Ray’s broad industry experience as a registered nurse, pharmacy manager, and cardiac device clinical specialist, as well as her hands-on sales and technical support for cardiovascular devices in the field, has prepared her to lead PaceMate with diligence and excellence.

While serving as a cardiovascular rhythm management representative with Medtronic and St. Jude Medical, Ray recognized a need for full-service remote monitoring. Combining her career expertise with her passion for making a difference, she and PaceMate co-founder Jason Hale hatched a plan that would become PaceMate.

Today, Ray serves as pioneering leadership for PaceMateLIVE, the customized cardiac implantable electronic device (CIED) monitoring software+service solution produced by PaceMate. Her goal is to add a unique level of compassion to the brand, setting a standard of equality in the medical workspace and causing it to shine through in the company’s customer service, mission, and core values.

Ray is a graduate of Louisiana State University-Alexandria with a Bachelor of Science degree with a major in Nursing and a Bachelor of Arts degree from Northwestern State University.

Jason Hale’s deep cardiac rhythm management experience with companies like Medtronic and St. Jude Medical has enabled him to create PaceMate®, a transformative digital healthcare company, leading the way in cardiac remote monitoring.

Hale’s patient-focused approach, his keen awareness of political and industry changes in the digital health marketplace, and his forward-thinking ability as it relates specifically to cardiac remote monitoring have set the stage for PaceMate®’s success.

Hale is a graduate of the University of Evansville with a bachelor of business administration degree in business, management, marketing, and related support services. Hale is a certified cardiac device specialist (CCDS), licensed by the International Board of Heart Rhythm Examiners (IBHRE).

Brian Faulknier is an experienced medical sales leader in the field of cardiac rhythm device management who brings a breadth of corporate healthcare expertise to his position as chief operating officer at PaceMate®.

After early career experience in device sales and support for multiple health tech start-ups—including leadership and training positions with Andrx Pharmaceuticals, Bard Peripheral Vascular, and FoxHollow Technologies—Faulknier advanced to become a multi-state principal sales representative with Medtronic and, most recently, EP territory manager for Abbott/St. Jude. He has steadily developed his capabilities as a teambuilder and mentor, winning awards for sales performance and maintaining an eye for company strategy and growth in equipment sales and support within the cardiovascular space.

As a skilled professional in overseeing CRM sales and support, understanding clinic organization, managing recruitment and new-hire training, conducting performance reviews, and utilizing various workforce technologies, Faulknier is well suited to serve as a senior leader at PaceMate®. His strategic planning, development of new business initiatives, and implementation and deployment of value propositions ultimately support all of the PaceMate® officers in clinical and business management.

Faulknier cites his collegiate Division I basketball career at Marshall University as the building block he uses to create the culture of teamwork that is evident at PaceMate®. His fond memories from MU include meeting his wife, making lifelong friends, and graduating with honors from the Marshall University School of Biological Science.

As PaceMate’s Vice President of People and Culture, McCullough “Cully” Buchanan is responsible for the planning, directing, and coordinating of PaceMate’s human resources. Her expertise and passion lie in assisting various healthcare environments—multi-site, remote, multi-state organizations, start-ups, and newly acquired facilities—with successful operational scaling.

Prior to joining PaceMate, Cully served in various senior leadership roles within healthcare and technology industries over the past twenty years. She is originally from Virginia, where she served as the Senior Director of Human Resources for Universal Health Services, supporting eleven locations throughout Washington, D.C., Virginia, and Maryland. Her prior roles also include work as the Vice President of Human Resources for a continuing care retirement community in Dunedin, FL; as Director of Human Resources for Medical Facilities of America; in HR Management with Rehab Management, Inc., where she supported fifty long-term care facilities in three states; as Director of Human Resources for a SaaS provider, Spirion, supporting employees in fifteen states and internationally; as Director of People and Culture for a remote organization, Skillable; and most recently as Vice President of People & Culture for HealthAxis Group LLC.

Cully has also actively participated in various roles within her community. She provides Meals on Wheels to seniors, and has served as an Executive Committee Member for The National Alliance on Mental Illness, as a committee member and judge for the Richmond Society for Human Resources Management “Employer All-Star Award” selection for employee engagement and retention, as an Executive Committee Member for The Virginia Society for Healthcare Human Resources Association, and as a Committee Member for Family Advocacy Creating Education and Services, where she testified before the General Assembly on behalf of Mental Health Courts.

Technology and product executive with 20+ years of experience building innovative SaaS solutions and integrating AI technologies that deliver measurable business outcomes and align with strategic business objectives.

Sean specializes in normalizing artificial intelligence, healthcare technology, and data-driven platforms for teams and customers, enhancing productivity and efficiency in clinical workflows. His previous work pioneering AI integration in healthcare management systems delivered significant efficiency improvements and enhanced patient outcomes through intuitive design and data-driven insights.

As a thought leader and public speaker on AI for executives, Sean bridges the gap between technical capabilities and strategic business implementation, focusing on product management and development that serves real clinical needs. He builds teams that deliver innovative solutions addressing genuine healthcare challenges rather than just pursuing technological trends, ensuring alignment with operational excellence and improved patient outcomes.

Dr. Tina Baykaner is an Instructor in Stanford University’s Department of Internal Medicine within the Division of Cardiovascular Medicine and Electrophysiology.

Following her internal medicine residency and her cardiovascular medicine and advanced heart failure fellowships at the University of California-San Diego and electrophysiology fellowship at Stanford, Dr. Baykaner joined the Stanford faculty in 2018. She has published over 200 papers, book chapters, and abstracts, including over fifty original peer-reviewed articles, and has delivered over twenty invited presentations in national and international meetings. She serves as section editor and editorial board member of four electrophysiology journals.

Dr. Baykaner’s current research interests include outcomes research, epidemiology, and mechanisms of rhythm disorders. She is currently funded by the National Institutes of Health to study patient-related outcomes regarding atrial fibrillation ablation. She received prior research funding from the American Heart Association and Heart Rhythm Society. Dr. Baykaner’s clinical practice focuses on ablation of atrial and ventricular arrhythmias, SVTs, inappropriate sinus tachycardia management, device implantation, and device extraction.

Dr. Baykaner is an active member of the American Heart Association, American College of Cardiology, Heart Rhythm Society, and European Society of Cardiology. She serves as an elected member of the Communications Committee for HRS and previously served as an elected member of the ACC Task Force ICD Research Committee. She also served on the Organizing Committee for the Stanford Cardiovascular Institute Annual Postdoctoral Research Meeting in 2017 and 2018 and for Early Career sessions for HRS Scientific Sessions in 2019 and 2020.

Dr. Thomas Deering serves as a cardiac electrophysiologist at the Piedmont Heart Institute in Atlanta where he is also Chief of the Arrhythmia Center, Chairman of the Clinical Centers for Excellence, and Chief Quality Officer.

In addition, Dr. Deering has served in a variety of volunteer roles for the Heart Rhythm Society, most recently as president from May 2018 to May 2019. His research and clinical interests are focused on defining and implementing quality initiatives in electrophysiology and cardiovascular medicine. He has served as a speaker and moderator at national and international electrophysiology and cardiology meetings; has authored and co-authored numerous publications addressing cardiac arrhythmia and cardiovascular quality issues; participates in a number of cardiac electrophysiology arrhythmia research projects; and serves as a reviewer for multiple cardiac electrophysiology and general cardiac journals.

Dr. Deering earned his medical degree from Yale University School of Medicine. After completing his post-graduate training at the Yale New Haven Hospital, he performed his cardiac electrophysiology fellowship at Tufts Medical Center in Boston. He has previously been a clinical assistant professor of medicine at the Yale University School of Medicine. At present, Dr. Deering is a clinical associate professor of medicine at the Medical College of Georgia and has been appointed to Piedmont Heart Institute’s Mark E. Silverman Endowed Chair in Cardiology and Education.

Dr. James Freeman is a clinical cardiac electrophysiologist with a focus on the ablation of complex arrhythmias (supraventricular tachycardias, atrial fibrillation and flutter, and ventricular tachycardia), and left atrial appendage occlusion.

He presently serves as Director of the Cardiac Electrophysiology Laboratories for Yale New Haven Health and as the Director of the Yale Atrial Fibrillation Program. Dr. Freeman has additional interests in implantable cardiac devices for cardiac arrhythmias and heart failure, including pacemakers, implantable cardioverter defibrillators (ICDs), and cardiac resynchronization therapy (CRT) devices.

A graduate of Johns Hopkins University School of Medicine, Dr. Freeman has also earned a master’s of public health with a concentration in biostatistics and epidemiology from Johns Hopkins and a master’s in health services research from Stanford. He has published extensively on topics of comparative effectiveness, cost effectiveness, and clinical outcomes with cardiac arrhythmias. With funding from the National Institutes of Health and the American College of Cardiology, Dr. Freeman is researching the safety and effectiveness of therapies for the prevention and treatment of atrial fibrillation, ventricular fibrillation/tachycardia, sudden cardiac death, stroke, and heart failure.

Dr. Freeman has participated in the Heart Rhythm Society New Leaders in Electrophysiology Leadership Program and is a fellow of the American College of Cardiology.

Dr. Eugene Fu serves as a cardiac electrophysiologist at OhioHealth Riverside Methodist Hospital in Columbus, Ohio, where he is also the System Medical Director for the OhioHealth Device Clinics.

Dr. Fu has a Bachelor's degree in Electrical Engineering (BSEE) from The Ohio State University College of Engineering. He earned his medical degree from The Ohio State University College of Medicine and completed his Internal Medicine Residency at OhioHealth Riverside Methodist Hospital. Dr. Fu completed his cardiology fellowship at Allegheny General Hospital in Pittsburgh, PA, and his electrophysiology fellowship at Virginia Commonwealth University in Richmond, Virginia.

In addition to his clinical practice, Dr. Fu has contributed to multiple multicenter clinical trials and authored and co-authored manuscripts on various device-related topics. He is particularly interested in implantable and wearable diagnostic device technologies and associated data management and has collaborated with industry leaders to develop best practices for an APP led ICM implant program.

Anne Kroman, D.O., Ph.D., is currently a practicing cardiac electrophysiologist and assistant professor of medicine at the Medical University of South Carolina (MUSC).

Dr. Kroman holds leadership positions at MUSC as the Director of the Electrophysiology Laboratories, Director of the Cardiac Device Program and Device Clinic and the Director of the Lead Management and Lead Extraction program.

Outside of MUSC, she holds positions in global societies such as the American College of Cardiology (ACC), the Heart Rhythm Society (HRS), Growth and Leadership of Women in Electrophysiology (GLOWE), Technical Aspects of Lead Extraction Symposium (TALES) and Women in Extraction group (WIE).

In addition to her regular responsibilities, she is involved in advancing the medical education of electrophysiology fellows, general cardiology fellows, and internal medicine residents worldwide.

Dr. Mittal earned his BA and MD degrees from Boston University as part of a combined 6-year BA-MD program. He did an internship and residency in Internal Medicine as well as a fellowship in Cardiovascular Diseases at the Hospital of the University of Pennsylvania in Philadelphia, Pennsylvania. He then completed a fellowship in Clinical Cardiac Electrophysiology at the New York Presbyterian Hospital-Weill Cornell Medical Center. Dr. Mittal is board certified in Cardiovascular Diseases and Clinical Cardiac Electrophysiology.

He is currently the Director of the Electrophysiology Laboratory and Chair of the Cardiovascular Service Line at The Valley Hospital in Ridgewood, New Jersey.

Dr. Mittal’s active research interests include the evaluation and management of patients with atrial fibrillation, the evaluation and management of patients with unexplained syncope, the role of implantable monitors in patients with known or suspected arrhythmias and overcoming barriers to remote patient monitoring.

He is a former member of the Heart Rhythm Society’s Board of Trustees. He is currently an Associate Editor of Cardiovascular Digital Health Journal and an Editorial Board member of Circulation: Arrhythmia & Electrophysiology, Journal of American College of Cardiology: Electrophysiology, Heart Rhythm, Heart Rhythm O2 and Journal of Interventional Cardiac Electrophysiology.

Dr. Andrea Russo is currently Professor of Medicine at Cooper Medical School of Rowan University. She also serves as Director of Electrophysiology and Arrhythmia Services and Director of the Clinical Cardiac Electrophysiology Fellowship Program at Cooper University Hospital in Camden, New Jersey.

Dr. Russo graduated from SUNY Upstate Medical Center in Syracuse, New York, completing an internship and residency at the Medical College of Pennsylvania in Philadelphia and fellowships in cardiology and electrophysiology at Cooper University Hospital.

In addition to her responsibilities as a professor, Dr. Russo is the immediate past president of the Heart Rhythm Society (HRS) and is a current member of the HRS Board of Trustees. She has authored multiple manuscripts on a variety of arrhythmia and device topics and has served as co-chair or member of various writing groups, including the publication of guideline, consensus, and appropriate-use documents.

Areas of special interest for Dr. Russo include sex differences in arrhythmias, implantable cardioverter defibrillators, atrial fibrillation therapy, and the role of digital health on arrhythmia management.

Professor Prash Sanders is a clinical and academic electrophysiologist based at the University of Adelaide, the Royal Adelaide Hospital, and the South Australian Health and Medical Research Institute (SAHMRI).

He was appointed to the Knapman-National Heart Foundation Chair of Cardiology Research at the University of Adelaide in 2005 and now leads the Centre for Heart Rhythm Disorders at the University of Adelaide and SAHMRI. In addition, Professor Sanders serves as the Clinical Director of Cardiac Electrophysiology and Pacing at the Royal Adelaide Hospital.

SAHMRI is South Australia’s first dedicated electrophysiology laboratory and research group and is now internationally recognized and positioned at the forefront of strategies for the treatment of atrial fibrillation. Dr. Sanders helps to lead this organization in the development and use of ablation techniques.

He is a practitioner fellow of Australia’s National Health and Medical Research Council (NHMRC) and has published over 300 peer-reviewed publications. He has received a variety of accolades, including being named the 2010 Australian Medical Researcher of the Year under the age of 40, an NHMRC Achievement Award for the highest ranked practitioner in 2013, and the RT Hall Prize from the Cardiac Society of Australia and New Zealand in 2015.

Dr. Sanders graduated from the University of Adelaide with honors and was trained as a cardiologist at the Royal Adelaide Hospital before sub-specializing in cardiac electrophysiology at the Royal Melbourne Hospital. His doctoral studies at the University of Melbourne were under the mentorship of esteemed Professor Jonathan Kalman and his postdoctoral studies were completed with the team of cardiac electrophysiology pioneer Michel Haissaguerre at the Hôpital Cardiologique du Haut-Lévêque and at Université Victor Segalen Bordeaux II in France.